Member Info for Daveavt

Will Align start buying? Lol, no they won't need to start buying as Align are paid to write those reports in share options. Align Research articles are the kiss of death, everyone knows that.

Yorkshire, when have I ever not said it's worth trading in the 5 to 8p range? That's all I ever say. And weren't you the other day mocking that 'look at the mid point, it's on the way up', and I said no it's hit saturation and it's on it's way down...and who was right, me once again, and now you're saying 'I am invested here at 6.19 average. Do I worry the SP may go lower? NO... '. So you've changed your tune accepting it can go lower? ;)

Glad to see you're agreeing with me now and see it trades nicely between 5 and 8, with yourself doing the same and trading the share. Careful though Yorkshire, you'll be classed as a deramper with that kind of post!

I don't disagree with anything you said either, and the share price does rise with a vengeance, to around 7 or 8p on news, as you can see on your charts. Anyone disagree?

Just to summerise about Merck Germany...'Germany’s Merck KGaA is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company’s separate liquid crystal business. The strategic review comes as Merck is grappling with declining sales at its liquid crystals business, a supplier of the chemicals used in LCD screens and a ** major source of cash flow for the group.** The highly profitable crystals business accounted for about 15 percent of group earnings last year, according to Deutsche Bank estimates, even after Merck sought to diversify by spending billions on takeovers in the laboratory supplies industry in recent years. https://www.reuters.com/article/us-merck-consumer/german-merck-considers-sale-of-consumer-health-business-idUSKCN1BG0R0 So, as per the article, Merck's LCD is their major source of cash flow..and for good reason. Low costs against revenues, where as the costs involved in developing biological products can be more than the revenues coming in, hence why they are looking to sell the healthcare division. But as I said, none of this actually matters as you're not invested in Merck, so I don't know why our resident 'professor' on here is trying to make it a big deal? Diversion tactic perhaps...

I just posted the facts to counter your rushed response, not that it actually matters what Merck Germany has in revenues, you're not invested in them, the point was it's not the multi billion Merck and Co in the US, if you had slowed down to read you'd realise, though I do like how you didn't try to counter any of the other points lol

I understood, it's just apple loves to go off on giant copy pastes lol

From Merck's own webpage, year ending 2017..'Healthcare generated sales of € 704 million (2016: € 753 million). The organic sales decline of -4.6% resulted primarily from performance in North America and Europe. The strong year-earlier sales in North America were due to a favorable competitive situation. Additionally, foreign exchange effects had an adverse impact of -1.8%. In 2017, the Consumer Health business generated organic sales growth in all main sales regions totaling 7.6%. Including currency headwinds of -0.5% and a portfolio effect of -1.0%, net sales of the business amounted to € 911 million (2016: € 860 million). This development was attributable especially to the global core strategic brands, particularly Neurobion and Nasivin, as well as the regional brand Vigantol, which is primarily marketed in Europe. In September 2017, Merck KGaA, Darmstadt, Germany, announced that it is preparing strategic options for the Consumer Health business. Life Science grows profitably in 2017. In 2017, the Life Science business sector generated organic sales growth of 5.3%, which was partly canceled out by negative foreign exchange effects of –1.7%. Net sales increased by 4.0% to € 5.9 billion (2016: € 5.7 billion). In 2017, all three business units contributed positively to the organic sales growth of Life Science. In 2017, net sales of the Performance Materials business sector decreased by -2.6% to € 2.4 billion (2016: € 2.5 billion). This was mainly due to an organic sales decline of -1.7% as the Display Materials business did not reach the previous year’s level. The stronger euro compared with 2016 also impacted the development of net sales by -0.9%.

https://www.reuters.com/article/us-merck-consumer/german-merck-considers-sale-of-consumer-health-business-idUSKCN1BG0R0

Exactly, it isn't. Though it is influenced by ramping and falsities, hence 'pump and dumps' and the reason it went to 30 and down to 6. What 'reason' do you think someone paid 25p plus, it was obviously the wrong ones, and do you think they made them all up in their head or read information from somewhere. The price drop is obvious, all that matters is revenues, and how much reaction over time news articles make to the share price. over time people have seen that revenues are nothing to write home about, and news releases haven't made any real shift in price, if any, so people sell and move elsewhere and the price drops. Come on that's pretty obvious really. Flip it the other way, I'll ask you, what reason would you give it to just rise?

In a nutshell, apple thinks the price is down at 6p because of me, yet ignores the fact it sat at 1p for over a year. And that's all I have to say lol...

'There must be hundreds that bought in at 10p 12p 15p 20p 25p 30'?.....because of idiot rampers like yourself? Probably. 'We have a contract with Merck, one of the biggest pharmas in the world!' - no, that's Merck & Co, we have a contract with a German company called MERCK KGaA who are the world's largest manufacturer of LCD crystals and pigments and have a healthcare division which only makes up 1/15th of their turnover'....'PYC have revolutionary patented tech that will save lives, they design cancer drugs'...no, they have 15 year old expired patent tech that only works out dosages for drug trials, they don't design drugs'....'Jason CROPPER is buying shares in thousands, he must know something follow the money!'...no don't follow the money I said as he is known for selling out in one go, which he did exactly that'. So yes, so many people caught up paying well over the odds because of idiots like yourself constantly spamming the boards with utter crap every single day, and hence why your in the top 4 on pumped or dumped. Aim will be a better place when you go.

You say that every week lol and never happens, 5s is where it's at and where it always goes to.

If the revenues are 300k and you paid 600k for half that, then that's about right. 150k revenues, what's the profit though. Thing is it's still next to no revenues.

^still couldn't help yourself lol

Leave then apple. Sell up and stop whining.

Ah true my mistake.

Have a look everything else they did that never happened, as this is just an m.o.u at present, then take into account this is a 51 percent share of a company that has no business in the uk, as stated at the bottom of the rns, then take into account ctea has 50 percent of the jv that's done the deal, so it's really 25 percent to ctea, then take into account this is background music for shops lol

This isn't 'streaming music' as you think of, this is a Dutch company that streams background music to shops etc

If you would be happy with 10p, you should have sold out when it last hit 8, bought back in when it drops down to 5s, and covered your losses and then some. Then again you could have punted it in any other share also, I did Farn this week.